Benzinga | Dec 8, 2020 07:02AM EST

SVB Leerink Maintains Outperform on Forma Therapeutics Hldgs, Raises Price Target to $65

SVB Leerink analyst Andrew Berens maintains Forma Therapeutics Hldgs (NASDAQ:FMTX) with a Outperform and raises the price target from $54 to $65.